子宫内膜癌诊断与治疗指南(第四版)

被引：288

作者：

周琦

吴小华

刘继红

李力

朱笕青

白萍

盛修贵

机构：

[1] 中国抗癌协会妇科肿瘤专业委员会

[2] 重庆市肿瘤医院/重庆大学附属肿瘤医院

[3] 复旦大学肿瘤医院

[4] 中山大学附属肿瘤医院

[5] 广西医科大学附属肿瘤医院

[6] 浙江省肿瘤医院

[7] 中国医学科学院肿瘤医院

[8] 山东省肿瘤医院

来源：

中国实用妇科与产科杂志 | 2018年 / 34卷 / 08期

关键词：

子宫内膜肿瘤; 诊断; 治疗; 指南;

D O I：

10.19538/j.fk2018080114

中图分类号：

R737.33 [子宫肿瘤];

学科分类号：

摘要：

<正>子宫内膜癌在发达国家是女性生殖系统最常见的恶性肿瘤,在我国居女性生殖系统恶性肿瘤的第二位,据2015年国家癌症中心统计,我国发病率为63.4/10万,死亡率21.8/10万。相关危险因素包括高水平的雌激素(可能由肥胖、糖尿病、高脂肪饮食引起),初潮早,未育,绝经延迟,林奇综合征(Lynch Syndrome),高龄(55岁以上)以及应用激素替代和他莫昔芬等。近年子宫内膜癌发病率呈现上升趋势。

引用

页码：880 / 886

页数：7

共 31 条

[1] Cancer statistics in China, 2015[J] . Wanqing Chen,Rongshou Zheng,Peter D. Baade,Siwei Zhang,Hongmei Zeng,Freddie Bray,Ahmedin Jemal,Xue Qin Yu,Jie He.CA: A Cancer Journal for Clinicians . 2016 (2)
[2] Utilization of Minimally Invasive Surgery in Endometrial Cancer Care: A Quality and Cost Disparity[J] . Amanda N. Fader,R. Matsuno Weise,Abdulrahman K. Sinno,Edward J. Tanner,Bijan J. Borah,James P. Moriarty,Robert E. Bristow,Martin A. Makary,Peter J. Pronovost,Susan Hutfless,Sean C. Dowdy.Obstetrics & Gynecology . 2016 (1)
[3] Long-Term Impact of Endometrial Cancer Diagnosis and Treatment on Health-Related Quality of Life and Cancer Survivorship: Results From the Randomized PORTEC-2 Trial[J] . Stephanie M. de Boer,Remi A. Nout,Ina M. Jürgenliemk-Schulz,Jan J. Jobsen,Ludy C.H.W. Lutgens,Elzbieta M. van der Steen-Banasik,Jan Willem M. Mens,Annerie Slot,Marika C. Stenfert Kroese,Simone Oerlemans,Hein Putter,Karen W. Verhoeven-Adema,Hans W. Nijman,Carien L. Creutzberg.International Journal of Radiation Oncology, Biol . 20
[4] Cancer statistics, 2015[J] . Rebecca L. Siegel,Kimberly D. Miller,Ahmedin Jemal.CA: A Cancer Journal for Clinicians . 2015 (1)
[5] The trend towards minimally invasive surgery (MIS) for endometrial cancer: An ACS–NSQIP evaluation of surgical outcomes[J] . Jennifer Scalici,Brittney B. Laughlin,Michael A. Finan,Bin Wang,Rodney P. Rocconi.Gynecologic Oncology . 2014
[6] Nomograms for prediction of outcome with or without adjuvant radiation therapy for patients with endometrial cancer: a pooled analysis of PORTEC-1 and PORTEC-2 trials[J] . Carien L. Creutzberg,Ruud G.P.M. van Stiphout,Remi A. Nout,Ludy C.H.W. Lutgens,Ina M. Jürgenliemk-Schulz,Jan J. Jobsen,Vincent T.H.B.M. Smit,Philippe Lambin.International Journal of Radiation Oncology, Biology, Physics . 2014
[7] Secondary analyses from a randomized clinical trial: age as the key prognostic factor in endometrial carcinoma[J] . Pierluigi Benedetti Panici,Stefano Basile,Maria Giovanna Salerno,Violante Di Donato,Claudia Marchetti,Giorgia Perniola,Antonio Palagiano,Alessandra Perutelli,Francesco Maneschi,Andrea Alberto Lissoni,Mauro Signorelli,Giovanni Scambia,Saverio Tateo,Giorgia Mangili,Dionyssios Katsaros,Elio Campagnutta,Nicoletta Donadello,Stefano Greggi,Mauro Melpignano,Francesco Raspagliesi,Gennaro C
[8] High-grade endometrial cancer: Revisiting the impact of tumor size and location on outcomes[J] . Kemi M. Doll,Jill Tseng,Sheri A. Denslow,Amanda Nickles Fader,Paola A. Gehrig.Gynecologic Oncology . 2013
[9] The benefit of adjuvant chemotherapy combined with postoperative radiotherapy for endometrial cancer: a meta-analysis[J] . Hyun Jong Park,Eun Ji Nam,Sunghoon Kim,Yong Bae Kim,Young Tae Kim.European Journal of Obstetrics and Gynecology . 2013 (1)
[10] Systemic and Local Hormone Therapy for Endometrial Hyperplasia and Early Adenocarcinoma
Hubbs, Jessica L.
Saig, Reagan M.
Abaid, Lisa N.
Bae-Jump, Victoria L.
Gehrig, Paola A.
[J]. OBSTETRICS AND GYNECOLOGY, 2013, 121 (06): : 1172 - 1180

← 1 2 3 4 →